Evidence map›Paper›PMID 32771630›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2020

Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.

Tyler J Varisco, Michael L Johnson, Douglas Thornton

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Tyler J VariscoDepartment of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Texas, United States.
Michael L JohnsonDepartment of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Texas, United States.
Douglas ThorntonDepartment of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, 4849 Calhoun Rd, Houston, TX 77204, United States; The Prescription Drug Misuse Education and Research Center, University of Houston College of Pharmacy, 4849 Calhoun Rd, Houston, TX 77204, United States. Electronic address: jdthornt@central.uh.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronavirus InfectionsPandemicsPneumonia, ViralAzithromycinBetacoronavirusCOVID-19COVID-19 Drug TreatmentHumansHydroxychloroquineSARS-CoV-2AzithromycinHydroxychloroquine

Identifiers

PMID32771630
PMCPMC7409789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.